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Background. Total knee arthroplasty (TKA) is becoming increasingly common 
in the United States. Over 3.4 million older US adults are predicted to undergo primary 
TKA annually by the year 2030, and over 4.5 million Americans already live with a 
primary knee prosthesis. Immediately following surgery, significant muscle atrophy 
occurs, compromising strength and functional mobility of the patient. Essential amino 
acid supplementation has been proven to mitigate post-operative muscle atrophy in 
TKA patients at the level of whole muscle, and this strategy has the potential to 
attenuate individual muscle fiber atrophy as well. Metl,ods. Data collection for this 
Honors Thesis is part of an ongoing double-blind, placebo-controlled randomized 
clinical trial. This Honors Thesis will present blinded raw data from 14 patients who 
have completed the study. Patients are randomized to ingest either 20 g of EAAs or 
placebo twice daily between meals for 1 week before and for 6 weeks after TKA. At 
baseline, 2 and 6 weeks post-TKA, an MRI was performed on each leg to measure 
muscle mass over time. In addition, each subject had bi-lateral biopsies performed in 
the operating room just prior to surgery and again at either 1 or 2 weeks post-TKA 
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(random allocation within each cohort). Digital analysis methods were developed to 
quantify muscle volume (MRI) and muscle cell cross-sectional area (histology) .  
Results. This blinded study is not yet complete and therefore this Honors Thesis will 
not report any results. The data reported are coded and randomized in order to maintain 
the integrity of the clinical trial. Conclusion. Unfortunately, the effectiveness of 
essential amino acid supplementation in attenuating muscle atrophy cannot be assessed 
in this Honors Thesis. However, the precision of the analysis techniques developed here 
can be evaluated and confirmed. Furthermore, the clinical importance of EAA 
supplementation in potentially decreasing post-operative muscle atrophy in TKA 
patients is substantiated as this surgery is becoming increasingly prominent in the US.  
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Introduction  
Total knee arthroplasty (TKA), or total knee replacement, is defined as the 
surgical reconstruction of the knee joint with the ultimate intention of restoring physical 
integrity and function to the damaged or degenerated joint. Total knee replacements are 
becoming increasingly common in the United States, with over 4.5 million Americans 
currently living with a primary total knee prosthesis1. Over 650,000 total knee 
replacements were conducted in 20101, and by 2030 it is projected that nearly 3.4 
million primary TKAs will take place in the United States annually2. Older individuals 
most often receive this treatment, with over 98% of TKA surgeries involving patients 
over the age of 451.  
The primary diagnosis leading up to TKA is osteoarthritis of the knee. This 
involves chronic inflammation, and progressive deterioration, of hyaline cartilage, 
eventually leading to bond-on-bone contact within the knee joint. This condition is 
painfully debilitating and severely limits movement about the knee joint, contributing to 
immobility and sedentarism in the affected patient. The adoption of an inactive lifestyle 
in response to this chronic injury greatly increases risk of mortality through increasing 
risk of developing cardiovascular and musculoskeletal pathologies, as well as metabolic 
syndrome3. Therefore, the implications of knee osteoarthritis should be considered 
serious and life threatening to those effected by it.  
A comprehensive solution is necessary to remedy the chronic pain associated 
with knee osteoarthritis in order to bolster active lifestyles and improve quality of life 
for the affected older population. Total knee arthroplasty is a remarkably successful 
treatment solution for patients suffering from chronic osteoarthritic knee pain. Over 
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95% of TKA patients (96% of whom were suffering from osteoarthritis) reported 
satisfaction with their surgical outcome and 90% reported dramatic pain relief as a 
result of surgery1. Increases in strength in the operative leg improve knee functionality 
after surgery4 and drastically improve overall quality of life for patients. However, 
surgery alone is insufficient in returning TKA patients to their preoperative levels of 
strength and function, even though their chronic knee pain is often remedied. Many 
patients experience significant quadriceps muscle atrophy post-operatively, ultimately 
compromising the ability to maximally regain knee strength and function to levels 
similar to healthy age-matched controls5,4,9,33. Muscle atrophy following TKA occurs at 
a rate of 1% per day for the first 2 weeks after surgery9.   Long-term muscle atrophy 
limits rehabilitation potential and diminishes complete recovery. Further complicating 
the situation, the older adult demographic receiving TKA inevitably experiences 
sarcopenia, or age-correlated muscle degeneration, in addition to post-operative muscle 
atrophy. Sarcopenia is experienced by almost half of people over the age of 80, and 
contributes largely to age related disability in general6. TKA exacerbates sarcopenia and 
accelerates total muscle loss in patients after surgery. In conjunction with one another, 
these atrophic factors greatly impede the ability of TKA patients to return to baseline 
levels of strength and function after surgery. Unfortunately, the atrophy in this context 
is likely permanent due to the age-associated muscle dysfunction inherent in 
sarcopenia15.  
There is therefore a present and increasing demand for improving post-operative 
recovery for TKA patients in order to attenuate the muscle atrophy associated with the 
rehabilitation process.  Decreasing overall muscle loss post-operatively translates into 
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shorter and easier recovery periods for patients, as well as a better end-result in regards 
to strength and function of the joint. It is known that essential amino acid (EAA) 
supplementation increases lean muscle mass7,8, and this has the potential to remedy the 
negative muscle atrophy experienced by patients undergoing a total knee replacement. 
In a 2013 study, Dreyer et al. found that twice daily ingestion of 20 grams of EAAs 
between meals for 1 week before TKA and 2 weeks-post helped reduce the degree of 
post-operative muscle atrophy and associated weakness in patients undergoing total 
knee arthroplasty9. These findings have far reaching clinical implications not only in the 
realm of total knee replacements, but in joint prosthesis in general. If essential amino 
acid supplementation can successfully remedy muscle loss post-operatively, simple 
administration of them before and after surgery could help patients with TKAs or other 
prostheses recover more quickly and completely after surgery.  
 A 2013 study published by Dreyer et al, showed that essential amino 
acid supplementation was successful in attenuating quadriceps and hamstrings/adductor 
muscle atrophy in TKA patients following surgery9. However, Dreyer and colleagues 
did not address how muscle fiber cross-sectional area was affected by EAA 
supplementation during recovery. Therefore, the primary purpose of this study is to 
assess how twice daily ingestion of 20 grams of EAAs for 1 week before and 6 weeks 
after TKA influences changes in muscle cell cross-sectional area. Secondarily, this 
study seeks to confirm their previous findings (Dreyer et al, 2013) that EAA 
supplementation attenuates muscle loss and accelerates the return of functional mobility 
at 6 weeks post-TKA. By coupling muscle cell cross-sectional area data from 
histological analysis with muscle volume data from MRI scans, this Honors Thesis aims 
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to assess the effectiveness of EAAs in deterring muscle atrophy at both the whole-
muscle and cellular level. This bilateral approach aims to address how individual 
muscle cell alterations ultimately affect whole muscle structure and function after TKA. 
It is hypothesized that twice daily ingestion of 20 grams of essential amino acids will 
decrease muscle atrophy (both volume and cross-sectional area) of the quadriceps 
muscle group in both the operative and non-operative leg following total knee 
arthroplasty.   
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Background 
Osteoarthritis 
Chronic osteoarthritis (OA) is a crippling condition in which joint articular 
cartilage and its underlying bone become progressively degenerated, resulting in pain 
and stiffness during movement. OA is currently the most common reason for 
hospitalization for adults aged 45 to 85 in the United States, with a 160% increase in 
admission rates between 1997 and 201110. Prevalence of osteoarthritis will increase 
drastically by 2030, with over 67 million adults (totaling 25% of the adult population) 
predicted to experience the debilitating symptoms11. In terms of pathologic origin, 
osteoarthritis results from a failure in the joint's repair process whereby damaged 
cartilage fails to be replaced with new and healthy cartilage as a function of 
biomechanical and biochemical alterations in the joint space12. Ultimately, an 
imbalance develops favoring degradation of chondrocytes and the extracellular matrix, 
producing a vulnerable joint environment unable to withstand continued mechanical 
stress. Being avascular, cartilage is largely restricted from blood circulation, and thus 
essential nutrients and oxygen availability in the event of an injury. Cartilage is also 
aneural, meaning that these degenerative joint changes fail to produce clinical 
symptoms until adjacent innervated tissues, such as bone, become damaged12. 
Consequentially, OA is often diagnosed late and patients can sustain severe cartilage 
diminution before intervention is enacted.  
OA of the knee is the diagnosis in over 96% of TKA cases, making it the 
principle diagnosis associated with this surgery1. Knee osteoarthritis, specifically, is 
characterized by progressive deterioration of the hyaline articular cartilage and bone of 
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the knee, accompanied by ligament and tendon alterations, resulting in inflammation of 
the joint space and painful, constrained ambulation13. This cartilage loss eventually 
progresses into bone-on-bone contact between the distal femur and proximal tibia, 
resulting in intense pain during articulation. TKA is most often prescribed to remedy 
this pathology, and it is remarkably effective in reducing pain caused by OA by directly 
removing the source. However, many confounding factors complicate post-operative 
recovery and limit a patient’s ability to return to their pre-operative levels of knee 
strength and function.  
Sarcopenia 
The generally older population experiencing OA and the associated pain often 
suffers from skeletal muscle deficiencies due to sarcopenia. Sarcopenia is defined as the 
progressive and involuntary loss of skeletal muscle mass as a function of normal aging. 
It is a phenomenon that contributes to development of frailty in old age,14 and is directly 
related to increased risk of falls, development of disability, and loss of independence15. 
In the year 2000, it is estimated that the United States spent $18.5 billion on healthcare 
directly attributable to sarcopenia, accounting for 1.5% of total healthcare costs that 
year16. After the age of 35, 3-8% of total skeletal muscle mass may be lost per decade 
due to sarcopenia, and this loss is accelerated after 60 years of age17,18. Muscle power 
output simultaneously decreases with age19 and likely accounts for the observed 
discrepancies in the elderly relating to functional independence,20,21. The quality of 
skeletal muscle components also declines with age, negatively influencing cross-bridge 
cycling and excitation-contraction coupling, further exacerbating functional declines in 
older individuals17.  
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The etiology of sarcopenia remains unknown, although it is likely caused by a 
varying combination of possible cellular mechanisms. These include declines in 
conduction velocity of motor neurons (specifically type II), motor unit loss, muscle cell 
loss, interference in excitation-contraction coupling, mitochondrial DNA deletions, 
alterations in satellite cell physiology, hormonal changes, impaired tissue response to 
nutrients, malnutrition, all of which are exacerbated by a lack of physical activity15. 
Regardless of the individual involvement of each of these contributing factors, it 
remains that the muscle fiber atrophy associated with sarcopenia is due to an imbalance 
between muscle protein synthesis and breakdown. There is evidence to suggest that the 
muscle protein synthesis pathway in sarcopenic adults is not disrupted due to a lack of 
difference in anabolic response between healthy young and old adults in response to a 
protein (essential amino acid) stimulus15. Therefore, the catabolic pathway seems to 
dominate protein turnover in older adults experiencing sarcopenia, resulting in a net 
decrease of muscle protein content and explaining the diminished muscle mass and 
force production. 
The atrophy associated with sarcopenia also has a dramatic influence on bone 
health. The connection between osteoarthritis and sarcopenia serves to manifest the 
important relationship between skeletal muscle mass and bone strength in the elderly. 
The application of mechanical force on bone increases bone modeling and remodeling, 
processes which ultimately increase bone mass and strength22. Considering that the 
greatest amount of force applied to bones is from skeletal muscle22, it is clear that 
voluntary contraction of muscle contributes to bone mass and strength. As sarcopenia 
progresses and muscle mass diminishes, the ability of muscle to provide adequate force 
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on bone for remodeling declines, and accordingly, bone health suffers. Thus, muscle 
loss is accompanied by bone loss. In fact, quadriceps weakness (15%-18% below 
baseline) is associated with development of osteoarthritis in a number of studies23,24. 
This highlights the importance of muscle mass retention on overall health and mobility, 
especially in the elderly. 
The Knee Joint and the Quadriceps Muscle Group: Functional Stability 
The knee joint is the largest and most superficial joint in the human body. 
Although well constructed, this synovial joint is considered relatively weak due to the 
variance in shape of its articular surfaces, as well as its requirement of adequate muscle 
mass for proper strength and function25. The quadriceps femoris muscle group performs 
extension of the knee and stabilizes it during ambulation by serving as one of the most 
powerful muscle groups in the human body. The quadriceps group is comprised of 4 
muscles, the rectus femoris, vastus lateralis, vastus intermedius, and vastus medialis. 
Common practical function of these muscles includes walking, running, jumping, rising 
from sitting or squatting, or climbing stairs. Considering many elderly people, and 
especially those with osteoarthritis11, experience increased difficulty performing these 
activities with age, it is clear that maintaining specifically quadriceps function through 
muscle mass retention is of primary concern in keeping the elderly dynamically stable26. 
This becomes even more important in the context of an elderly patient undergoing a 
total knee arthroplasty.  
A severe decline in specifically quadriceps muscle mass and strength has been 
observed for TKA patients during the post-operative recovery process9,27, and this is 
highly correlated with declines in functional mobility more so than other measures of 
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physicality34. Dreyer and colleagues observed an 18% reduction in quadriceps muscle 
mass in control TKA subjects 6 weeks after surgery9. Considering the patient 
population, the combined degenerative effects of sarcopenia and low mobility seem to 
have combined negative affects on quadriceps muscle mass and appropriately affect 
functional mobility post-operatively. Quadriceps weakness can also encourage further 
injury in the patient. Weakness in the operative leg causes changes in movement 
patterns that result in increased loading of the non-operative leg, exacerbating potential 
osteoarthritic damage in the non-operative leg and risking necessity for contralateral 
knee replacement in the future28.  
Mobility Reduction and Muscle Atrophy 
Postoperative mobility impairments directly challenge TKA patients’ efforts to 
return to their preoperative levels of knee strength and function. While not rendered 
completely immobile, TKA patients remain severely limited in activity after surgery; 
despite twice-daily physical therapy sessions that begin postoperative day one. 
Extensive loss of muscle mass, strength, and function as a product of prolonged 
hospitalization and reduced mobility likely contribute to a longer recovery times for 
patients after surgery29. Models of disuse atrophy in human subjects indicate a decrease 
in muscle protein synthesis of approximately 60%, as well as a reduction in the anabolic 
stimulus of EAAs by 50%, after four weeks of sustained immobility30. This decrease in 
muscle protein synthesis results in a loss of 0.3% - 0.8% muscle cross-sectional area per 
day30,31. This loss in muscle mass associated with surgery and recovery is likely to 
accelerate sarcopenia in elderly patients9, ultimately extending recovery times and 
limiting positive clinical outcomes. The atrophy experienced by older patients during 
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this period is likely permanent15, which severely compromises long-term functional 
gains32. In addition, immobility-derived muscle loss sustained preoperatively due to 
chronic knee pain further challenges recovery efforts by decreasing baseline skeletal 
muscle mass. This likely occurs because of the time delay between the onset of 
osteoarthritic symptoms and surgical intervention, which may require years to achieve. 
Thus, it follows that patients suffering from chronic knee osteoarthritis have about two-
thirds the quadriceps muscle mass of comparative adults33. It is clear that patients 
undergoing a total knee replacement are functionally challenged post-operatively, and 
attenuation of atrophy in the quadriceps muscle group is directly correlated to 
improvements in strength and function, ultimately translating to shorter recovery times 
and better overall outcomes for patients.  
Attenuating Muscle Atrophy 
In general, administering hormones, performing exercise, and manipulating 
nutrition are all potential strategies in attenuating loss of muscle mass and function14. 
Hormonal therapy such as the use of testosterone or epinephrine/cortisol blockers has 
positive effects on muscle loss and function, however, treatment involving them is often 
accompanied by undesirable and unpredictable complications. Therefore, the use of 
hormones in this clinical context is limited14. Exercise increases functional mobility in 
elderly patients experiencing sarcopenia, however, it does not seem to actually attenuate 
loss of muscle mass14. However, some studies indicate early onset of exercise post-
operatively aids in recovery of functionality and provides a "higher plateau" for 
improvement, translating to more independence and mobility34. However, the elderly 
population primarily receiving TKA is largely limited in their ability to perform 
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resistance exercise as a function of osteoarthritic pain and compromised muscle mass 
from sarcopenia. Therefore, this strategy, too, is limited in the cohort of subjects under 
investigation. Although hormonal therapy and exercise seem to be ineffective strategies, 
manipulation of nutrition has vast potential for remedying loss of muscle mass and 
function.  
It is known that high-protein diets increase protein synthesis based on expansion 
of amino acid availability35, and this phenomenon happens dose-dependently36, 
meaning that higher rates of protein intake correspond to higher rates of protein 
synthesis. Ingestion of dietary protein above DRI values is known to stimulate the 
fractional synthesis rate (FSR) of muscle protein during protein turnover37, and this is 
positively correlated with strength increases38. It is likely that higher muscle protein 
turnover rate results in formation of new myofibrillar proteins that ultimately function 
with greater capacity14. Essential amino acid supplementation increases muscle mass, 
strength and function similarly to a high protein diet, independent of exercise39,40. In a 
recent study, elderly individuals who daily ingested amino acids above normal dietary 
recommendations for 3 months had improved muscular strength and function41. In 
addition, it is likely that amino acid supplementation also increases skeletal muscle 
metabolic function by increasing mitochondrial protein synthesis, ultimately allowing 
for greater oxidative efficiency42. These findings have far reaching clinical implications. 
If simple oral supplementation of amino acids improves muscle strength and function, 
simple administration of them could help attenuate muscle loss both from sarcopenia 
and the impaired mobility associated with hospitalization and post-operative recovery. 
Findings from the Dreyer Lab provide proof-of-principal for the potential of essential 
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amino acid supplementation to attenuate muscle loss post-operatively in older adults 
having TKA9, providing inspiration for this study.  
Nutrition and muscle protein synthesis seem to be negatively affected by the 
narcotics often prescribed to patients after surgery to manage pain and encourage range 
of motion in the operative knee. Hydrocodone/acetaminophen, oxycodone, and dilaudid 
(hydromorphone) are common opioid narcotics prescribed to patients after TKA to 
manage pain. In a recent review, Wiffen et al. found that anorexia or decreased appetite 
was a side affect of opioid use in 1 out of 8 prescribed patients43. Partial or complete 
loss of appetite could result in a decrease in dietary protein ingestion and the absence of 
the associated anabolic stimulus. This could ultimately encourage muscle atrophy if 
muscle catabolic processes remain active. Dreyer et al. observed a decrease in protein 
ingestion in control subjects 2 weeks after TKA, and they surmised that this dietary 
deficiency could be a contributing factor to postoperative muscle atrophy and observed 
declines in strength and function9. It is possible that narcotic use following surgery 
could contribute to this decrease in dietary protein ingestion through appetite 
suppression.   
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Methods  
Subjects 
The subject pool for this experiment consisted of adult males and females 
between the ages of 50 and 80 who were scheduled to undergo primary total knee 
arthroplasty (TKA). The study aimed to enroll 40 subjects. For the analysis presented 
here, 14 of the 40 subjects had completed the experimental protocol. Through 
collaboration with Slocum Center for Orthopedics and Sports Medicine in Eugene, 
Oregon, subjects were chosen from a pool of potential candidates scheduled to receive a 
primary knee joint prosthesis. Candidates were cleared prior to inclusion into the study 
for various preexisting medical conditions, such as significant heart, kidney, liver, or 
blood disease, untreated endocrine disease, peripheral vascular disease, active cancer, or 
past treatment with anabolic steroids or oral corticosteroids (>1 week). Patients 
undergoing a revision total knee arthroplasty were also excluded due to possible bias in 
recovery process expectations. All subjects completed a detailed informed consent 
agreement before participating in the study. Upon enrollment, each subject was 
assigned to either a treatment (EAA) or placebo group (NEAA) using a set of random 
assignment procedures designed by the Principal Investigator. Considering the double-
blind nature of this study, all researchers were unaware of the group-identity of the 
subject, and all subjects remained unaware of their placement within the groups. 
 
Trial Design 
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This placebo-controlled, double-blinded study began in January of 2015 with 
Dr. Hans Dreyer as Principal Investigator. The study incorporates a dual armed, 
parallel-designed trial with a group allocation ratio of 1:1 between treatment and 
placebo groups. All subjects completed MRI imaging at 2 weeks pre-TKA (baseline), 2 
weeks post-TKA, and 6 weeks post-TKA for the purpose of analyzing quadriceps 
muscle volume. Muscle biopsies were obtained on the morning of the TKA operation, 
and at either 1 week post-TKA or 2 weeks post-TKA (randomized), for the purpose of 
analyzing muscle fiber cross-sectional area. Baseline measures of quadriceps volume 
and muscle cross-sectional area were obtained prior to the total knee replacement, as 
well as before the introduction of amino acid treatment (MRI only).    
Figure 1: Trial design timeline 
This timeline illustrates the trial design and time points of data acquisition. Arrows in 
blue represent MR image acquisition; Arrows in green indicate muscle biopsy 
acquisition (* denotes second biopsy – each subject contributed one biopsy at either 
randomly selected time). Arrow in red indicates day of TKA operation. Dotted line in 
pink represents duration of amino acid supplementation (twice daily, 49 days total). 
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Supplementation  
Subjects in the treatment group were orally administered a regime of 20 grams 
essential amino acids (EAA) twice-daily for 1 week before, and 6 weeks after TKA. 
The placebo group was twice- daily given 20 grams nonessential amino acids (NEAA) 
for the same duration. Supplementation began one week prior to the TKA operation, 
resumed again one day post-surgery, and continued 42 additional days, for a total of 49 
days of supplementation. Ingestion of the amino acid supplement occurred at 10 am and 
2 pm daily. After surgery and during inpatient hospitalization, subjects ingested their 
morning supplement one hour after their early physical therapy session. Subjects 
ingested their second daily supplement an hour after completion of their afternoon 
physical therapy session. Subjects completed three physical therapy sessions per week 
for the first two weeks after TKA intervention. Supplement ingestion occurred after 
regularly scheduled physical therapy sessions in order to maximize the anabolic effects 
of the essential amino acids in muscle protein synthesis44,45. Subjects were encouraged 
to continue this behavior after inpatient hospitalization in outpatient rehabilitation. The 
composition of the essential amino acid supplement was: histidine, 2.2 g (11% of total); 
isoleucine, 2.0 g (10%); leucine, 3.6 g (18%); lysine, 3.2 g (16%); methionine, 0.6 g 
(3%); phenylalanine, 3.2 g (16%); threonine, 2.8 g (14%); and valine, 2.4 g (12%). 
Subjects in the placebo group were administered a supplement of 20 g (100%) alanine 
(non-essential amino acid). The EAA concoction was mixed offsite at Northwest 
Compounders in Tualatin, Oregon. A study coordinator distributed either the EAA or 
NEAA supplements, which were coded to ensure blindedness of researcher and study 
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subject. Records of supplementation were maintained throughout the study and were 
routinely monitored by research personnel during regular visits.  
Total Knee Arthroplasty 
On the morning of the operation, each subject was admitted to Sacred Heart 
Medical Center at RiverBend (Springfield, Oregon) in a postabsorptive state. Either an 
epidural, spinal, or general anesthesia was administered. Intravenous Propofol was used 
to initiate general anesthesia, and either inhalational desflurane or sevoflurane 
(sometimes combined with a muscle relaxant, rocuronium bromide) was used to 
maintain anesthesia throughout the surgery. A 10-cm wide Zimmer inflatable tourniquet 
was placed on the proximal third of the operative thigh and inflated to 300 mmHg in 
order to minimize perfusion during surgery. The tourniquet was removed after the 
major components of the surgery were completed to allow reperfusion of the operative 
limb. 
MRI Acquisition 
All magnetic resonance imaging for the study was conducted at the Lewis 
Center for Neuroimaging (LCNI) at the University of Oregon in Eugene. Patients 
arrived at LCNI two weeks prior to their scheduled TKA surgery for baseline MRI 
scans of the bilateral lower extremities between the anterior iliac spine of the pelvis and 
the tibial plateau. A Siemens Magnetom Skyra T3 system was used to acquire 90-2mm 
thick transverse slice images using the following scan parameters: T1 weighted; TR: 
600 ms; TE: 9.9 ms; echo spacing 9.86 ms; 2D Distortion Correction and Prescan 
Normalize filters; minimum flip angle 150°. Automatic table repositioning was used 
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during the three employed 90-slice scans to grant contiguousness between slices. The 
subject was positioned supine within the scanner and two flexible Siemens Body 18 
coils (18 channel, phased arrayed coils) were placed and adjoined anteriorly over the 
subject’s pelvis and distal femur to acquire images in the area of interest. A Siemens 
Spine 32 array coil was used in conjunction with the Body array coils, and was located 
posteriorly underneath the subject during the scans. Early in the study, placement of the 
flexible Body coils directly on the subject resulted in anteromedial visual interference in 
the image. This interference greatly complicated data analysis. By including an 
additional layer of foam (appx. 1.5 cm), the interference was dampened and the issue 
was resolved. The Dixon technique was applied to obtain additional “water” and “fat” 
images, which served useful in the analysis protocol. Patients returned to LCNI for 
additional MRI acquisition two weeks and six weeks post-TKA, and the same scan 
parameters and equipment were employed. Images for the study were made available to 
the Principal Investigator, who then concealed the subject identity and time point of 
acquisition before releasing each set of scans for analysis. 
MRI Analysis, Determination of Quadriceps Volume 
Each of the subject’s three image subsets (2w pre-op, 2w post-op, 6w post-op) 
was encoded by the Principal Investigator to ensure blindedness during analysis. The 
Principal Investigator produced a single 9-image sequence (referred to as a stack) from 
each subset; each stack consisted of three sub-sequences, each of which was applied 
with a different image filter – “muscle”, “water”, or “fat”. Each of the three sub-
sequences within the 9-image stack was comprised of three images (proximal, middle, 
distal thigh) from the area of interest. Each sub-sequence consisted of the same three 
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images, albeit under different filters. Images (1-3) consisted of a proximal, middle, and 
distal image under the “fat” sub-sequence filter. Images (4-6) consisted of the same 
three images under the “muscle” sub-sequence filter. Similarly, Images (7-9) were the 
identical images under the “water” sub-sequence filter.  Images were chosen from the 
mid-thigh region (~5 cm window) based on clarity and lack of distortion/interference. 
Figure 2 shows an example of a single image stack utilized for analysis.  
 
Figure 2: A single image stack for a subject.  
Images [1,2,3] represent a “fat” sub-sequence; Images [4,5,6] represent a “muscle” 
sub-sequence; Images [7,8,9] represent a “water” sub-sequence. Images [1,4,7] are 
identical proximal thigh images; Images [2,5,8] are identical middle thigh images; 
Images [3,6,9] are identical distal thigh images.  
 MR image analysis was conducted using ImageJ, a dynamic Java-based 
computer application developed by the National Institutes of Health (NIH). A single 9-
image stack (Figure 2) was imported into ImageJ in RGB (red, green, blue) format. 
While all three image sub-sequences were available during analysis, only the “fat” sub-
sequence (Images [1,2,3]) was used to quantify area of muscle because it manifested 
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contrasts between muscle and fat most accurately (Figure 3, Image 1). Beginning at 
Image 1, the Wand tool, which uses a tolerance gradient (1-100) for selection of similar 
particles based on color homogeneity, was used (tolerance = 25) to highlight the femur 
and quantify its area in the proximal, middle and distal image (Figure 3, Image 2). Area 
of the femur for each image was then recorded. The Wand tool (tolerance = 25) was 
used again to select and remove subcutaneous fat from the cross-sectional image of the 
thigh. Left with exclusively the skeletal muscle of the thigh (Figure 3, Image 3) the 
quadriceps muscle group was separated from the hamstrings muscle group by tracing 
both the medial and lateral intermuscular septums, which divide the anterior and 
posterior compartments of the thigh (Figure 3, Image 4). This manual delineation was 
verified for accuracy by cross-referencing the tracing with the identical images in other 
sub-sequences (“muscle” and “water”). This “raw” area of the isolated quadriceps was 
measured in the proximal, middle, and distal Images (1-3) and was recorded. Next, 
intramuscular fat was isolated from skeletal muscle by using a thresholding procedure 
to select and quantify fat within the muscle based on a range of particle shades. Prior to 
thresholding, the image stack was converted from RGB format to 8-bit, or binary, 
format. In addition, the medullary cavity of the femur, which appears light grey in the 
Image, was selected and darkened in Images (1-3) order to ensure its area was not 
included in quantification of intramuscular fat. Manual thresholding using the “Otsu” 
method was chosen because it minimizes intra-class variance within each of the two 
tissue types (muscle and fat) and maximizes inter-class variance between them46. 
Beginning at Image 1, the upper bound of the selection module was set to near 
maximum (254/255) (maximum would include the white background in the selection) 
 20 
 
in order to include the lightest possible shades in the threshold window. The lower 
bound was then manually manipulated to include as much intramuscular fat as possible 
in the threshold window (selected particles appear red) without including skeletal 
muscle (Figure 3, Image 5). The area of these selected particles was then measured and 
recorded. This procedure was repeated for Images 2 and 3. Quadriceps muscle area was 
calculated by subtracting the raw quadriceps area (Figure 3, Image 4) from the 
combined area of the femur and intramuscular fat for each image.  
 
Figure 3: Image series detailing muscle volume determination from an MRI stack 
[1] displays an unedited MRI image of the “fat” subsequence. [2] shows the femur 
highlighted in the image. [3] shows the skeletal muscle of the thigh, with 
subcutaneous fat removed. [4] shows the quadriceps muscle, separated from the 
hamstrings by tracing the intermuscular septums. [5] shows the intramuscular fat 
within in the quadriceps, highlighted in red using the thresholding tool.  
Prior to calculating quadriceps volume from the area measurements described 
above, each image set was assigned a scale for converting area measurements from 
1 2 
3 4 5 
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pixels2 to cm2. Because the view size of the image file often varied, each stack received 
its own scale. The green scaling bar denoting 10 cm (located on the left aspect of each 
image, see Figure 2) was measured within ImageJ in order to quantify the equivalent 
measurement in pixels. This ratio of (pixels/cm) was squared in order to get a (pixels2 
/cm2) ratio, which each area measurement was divided by in order to convert area 
measurements from pixels to cm.  
Quadriceps muscle volume for a subject was calculated by multiplying the 
average quadriceps area from the proximal, middle, and distal image of each subset (2w 
pre-op, 2w post-op, 6w post-op) by the total distance between the proximal and distal 
image. Counting the number of images located between the proximal and distal images, 
and multiplying by the slice thickness of 2 mm, rendered this quantity. Distance was 
approximately 5 cm for each stack, though it varied based on the location of each image 
within the subset chosen for analysis. A “distance factor” of 10% was added to each 
distance measurement to account for the 0.2 mm separation between slices within each 
subset.  
Acquisition of Muscle Biopsies 
Muscle biopsies were obtained from the vastus lateralis muscle of both the 
operative leg and non-operative leg on the morning of TKA, and at 1 or 2 weeks post-
operation (randomized, see Figure 1). Each subject thus contributed four muscle 
biopsies for analysis. Baseline biopsy samples were obtained by the surgeon in the 
operating room (OR) prior to application of the tourniquet for surgery. Biopsies were 
obtained using a suction-modified Bergstrom biopsy needle, inserted into the muscle 
through a previously made 1-cm incision.  Correspondents from the Dreyer Lab 
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received and processed the tissue in the OR immediately after acquisition. Each biopsy 
was mounted on a short needle inserted through a 1-cm2 square of cork. This was then 
bonded with OCT (Optimal Cutting Temperature) compound to a cryostat chuck, before 
being frozen in isopentane cooled to the temperature of liquid nitrogen for 
approximately 30 seconds. Frozen samples were then transported back to the Dreyer 
Lab where they were labeled with the appropriate subject code and kept at -80° C.  The 
Principal Investigator performed the second biopsy in the Dreyer Lab facility at the 
randomly assigned time (1 or 2 weeks post-op). Standard aseptic procedures were 
performed and a local anesthesia [1% Lidocaine HCl (10 mg/mL)(Hospira Inc, Lake 
Forest, IL)(approximately 10 cc)] was employed during the procedure. Samples were 
processed identically as before and kept at -80° C for future analysis. 
Immunohistochemistry and Fluorescence  
Prior to histological preparation, the principal investigator retrieved a single 
subject’s four muscle biopsies (pre- and post-surgery, left and right leg) and assigned 
each a numerical code (1-4) to conceal the time point of acquisition. The pre-mounted 
samples were then placed in a Leica CM1850 UV cryostat and allowed to equilibrate to 
the cutting temperature of -21° C. Each of the four biopsies was cross-sectioned at 7 μm 
and serially collected in a single vertical row on two individual Fisherbrand Superfrost 
Plus microscope slides. Each biopsy contributed approximately 4-6 sections per row on 
both slides. Muscle sections were allowed to air-dry at room temperature for 
approximately 1 hour before being fixed in cold acetone (4° C) for 3 minutes. Slides 
were allowed to dry before a Pap Pen was used to circumscribe a hydrophobic barrier 
around the biopsy sections. Muscle sections were washed in PBS [(phosphate-buffered 
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saline)(3x3min)] before being incubated with rabbit anti-laminin primary antibody 
(IgG1 ((1:1000) in PBS, DAKO, Carpinteria, California)) or ((1:200) in PBS, Sigma 
Aldrich, St. Louis, Missouri) for 1 hour. Muscle sections were again washed in PBS 
(3x5 min) before being treated with 3% hydrogen peroxide (H2O2) in PBS for 7 
minutes to block endogenous peroxidase activity and non-specific staining. Sections 
were again washed in PBS (3x3 min) before being incubated with goat anti-rabbit IgG1 
secondary antibody (target is laminin antibody, above (AlexaFluor 488 
(1:500)(Invitrogen, Carlsbad, California))) for 1 hour. Muscle sections were washed in 
PBS (3x3 min) before 3% NDS (normal donkey serum; Jackson Immunoresearch, West 
Grove, Pennsylvania) in PBS was applied for 1 hour to block additional non-specific 
staining. Muscle sections were again washed in PBS (3x5 min) before being applied 
with SlowFade Diamond anti-fade mount with DAPI (labeling all 
nuclei)(ThermoFisher, Eugene, Oregon). VECTASHIELD Antifade Mounting Medium 
(Vector, Burlingame, California) was applied and a coverslip was placed on the sample. 
Sections remained at 4° C overnight (~12-16 hrs) before immunofluorescent images 
were obtained.  
Fluorescent Microscopy 
Muscle tissue cross sections were visualized and photographed using a Leica 
DM4000B fluorescent microscope, equipped with a high-speed Leica DFC360 FX 
camera, a DFC 295 color camera, and a Prior Lumen 200 epifluorescence light source. 
The Leica Application Suite (LAS) software was used for image acquisition. Beginning 
with the first section in row 1 (corresponding to the first biopsy), one laminin image 
was obtained from the visual field using λ=488 nm excitation light. Once the image was 
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taken and filed for a given location, the microscope stage was moved left, completely 
out of the current field of view, to expose a new group of cells for image acquisition. 
After the right border of the muscle section was reached, the stage was returned to its 
starting position on the left side of the slice, below the field of view of the previously 
captured image. The specific location of image acquisition within the muscle slice 
depended largely on the quality of the tissue and laminin stain at that site. Care was 
taken to avoid photographing the same cells multiple times. Eight individual fields of 
view were photographed per biopsy, encompassing 32 total laminin images per biopsy. 
Histological Analysis 
Skeletal muscle cell cross sectional area (CSA) was determined using ImageJ 
analysis software. Laminin immunofluorescent images were used during this analysis to 
identify the borders of each muscle cell in the field of view (Figure 4, Image 1). Each 
laminin image was individually imported into ImageJ. Image brightness and contrast 
were then simultaneously increased in order to intensify the extracellular matrix (ECM) 
signature, and to reduce the appearance of any non-specific background staining (Figure 
4, Image 2). The thresholding tool was then used to isolate the muscle cells (dark in the 
image) from the ECM (bright white). The threshold parameters were “applied,” and the 
image was converted to a manipulation-friendly binary image that separated individual 
muscle cells (white) from ECM (black)(Figure 4, Image 3). Any discrepancies in the 
ECM were manually amended with the Brush tool (width: 2-4) in order to fully 
complete the perimeter of as many cells in the window as possible. The identity of very 
small muscle cells was confirmed by cross-referencing the binary image with the 
original laminin image. Once the cellular borders in the binary image were augmented, 
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the image was cross-referenced with the original laminin image a final time to confirm 
the identity of the muscle cells as such. Confirmed muscle cells with an uninterrupted 
membrane lying entirely within the viewing window (not on the border) were colored a 
non-specific shade of grey for differentiation from damaged cells or non-muscle cells. 
This process was repeated until the entirety of muscle cells within the window was 
highlighted. The appropriate pixel-scale ratio (1.953 pixels/μm) was entered in the Scale 
window in order to convert area measurements from pixels to μm2. The thresholding 
tool was again used to select exclusively the grey-highlighted cells, excluding damaged 
muscle cells, non-muscle cells and the ECM. The Analyze Particles macro was used to 
expeditiously measure the cross-sectional area of the individual cells in the image. 
“Show Outlines” and “Display Results” were selected in the drop-down menu in order 
to auto-generate an outline “drawing”, or rendering, of the cell borders, along with area 
measurements for each cell (Figure 4, Image 4). The macro auto-assigned numbers to 
each cell, which coincided with individual area measurements listed in the Results table. 
Muscle cell cross-sectional area measurements were then imported into Microsoft 
Excel, where average fiber CSA was calculated for each biopsy. Each “drawing”, or 
rendering, of the group of cells was saved for reference purposes.  
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Figure 4: Image sequence detailing CSA determination from a single laminin-stained 
muscle biopsy image (7 μm).  
[1] shows an unedited laminin image. [2] shows the image with enhanced 
brightness/contrast. [3] shows the image in binary form, converted using the 
thresholding procedure. [4] shows the “drawing” of the laminin image, with 
individually numbered muscle cells, generated by the “Analyze Particles” macro 
within ImageJ.  
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Results  
 At the conclusion of this Honors Thesis, the study presented here 
remains ongoing due to requirements for additional subjects as per the National Institute 
of Health (NIH) grant funding this research. Because only 14 of the required 40 subjects 
completed the experimental protocol at the conclusion of this Honors Thesis, the data 
must remain blinded so as to eliminate bias in further analysis. Therefore, subject group 
identity (treatment vs. placebo), as well as time point of data acquisition of both MRI 
scans and muscle biopsies remains encoded and unknown. Consequentially, subject data 
cannot be allocated to groups for statistical analysis. Therefore, the discussion of results 
in this study is highly limited because changes in both muscle volume and muscle cross-
sectional area cannot be compared with baseline values. Nevertheless, analysis was 
conducted on the blinded data of the 14 subjects that completed the experimental 
protocol, and this raw data is located in the Appendix. Figures for quadriceps cross-
sectional area (CSA) and quadriceps muscle volume were reported together for each 
subject. Figure 4, shown below, is an example of one subject’s dataset.  
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Figure 5: Quadriceps muscle cross-sectional area (CSA) and muscle volume for a single 
subject.  
The bar graphs above display quadriceps CSA and muscle volume for Subject 1232. 
Each of the four muscle biopsies (pre- and post-surgery, left and right leg) used to 
quantify quadriceps CSA were assigned a random numerical code (1-4) by the 
Principle Investigator to ensure blindedness during analysis. The numbers positioned 
above each column in the CSA figure indicate the number of muscle cells analyzed 
for that biopsy. The 3-digit numbers listed below each column in the quadriceps 
volume figure represent a time point of MRI acquisition (2w pre-op, 2w post-op, 6w 
post-op), and were also encoded by the Principle Investigator. All are ordered least-
to-greatest in numerical order. "R" and "L" refer to right and left leg. Error bars in 
both charts represent ± standard error of the mean (SEM). Data for all 14 subjects 
analyzed for this study are listed in the Appendix.  
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Discussion  
The primary purpose of this study was to determine how twice daily ingestion of 
20 grams of essential amino acids (EAAs) for 1 week before and 6 weeks after TKA 
influenced changes in muscle cell cross-sectional area following surgery. Secondarily, 
this study sought to confirm findings by Dreyer et al. that EAA supplementation 
attenuates muscle loss and accelerates the return of functional mobility at 6 weeks after 
TKA9. It was hypothesized that twice daily ingestion of 20 grams EAAs would 
attenuate muscle cell and whole-muscle atrophy of the quadriceps in both the operative 
and non-operative leg after TKA.  
Unfortunately, because this double-blind study is incomplete and ongoing due to 
requirements for additional subjects stipulated in the supporting NIH grant, the results 
cannot be unblinded here for analysis. The concealment of subject identifying 
information, group allocation, and time point of data acquisition, is essential in this 
study in order to remove potential bias on the part of the researchers. Removing these 
elements before the experiment is complete would compromise its status as a 
randomized, placebo-controlled, double blind study and ultimately invalidate it. 
Subsequently, evidence-based conclusions about the effectiveness of EAA 
supplementation in attenuating muscle atrophy after TKA cannot be made here because 
they would be merely conjecture. 
However, conclusions can be made about the efficacy of the analysis methods 
developed for this Honors Thesis. The digital strategies designed to determine muscle 
cell CSA and volume are accurate, objective, and yield highly reproducible results. 
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Both methods systematically isolate different tissue types in both contexts, allowing for 
easy quantification of various muscle parameters.  
Intra- and inter-class variance analysis was conducted on these methods in order 
to determine their consistency in measurement. These metrics indicate the objectivity 
and reproducibility of the analysis techniques. Intra-class variance analysis was 
conducted on the muscle volume quantification protocol in order to determine the 
percent difference between measurements of the same dataset over the course of the 
study by a single researcher. This analysis yielded an approximately 2-3% change 
between quadriceps volume measurements conducted at different time points in the 
study. This value is low and well within the accepted range of precision for this analysis 
protocol (<10%).  
Similarly, Inter-class variance was conducted to determine the percent 
difference in measurement between separate researchers analyzing the same dataset. 
These values varied between 0.5%-3.4% and were also well within the accepted range, 
indicating proficiency and precision of technique (<10%).  Intra-class variance analysis 
was also conducted on the muscle fiber CSA protocol. The analysis yielded a 0.15% 
change between average fiber CSA for a subject’s single biopsy, measured at different 
time points in the study. This value, too, is low and well within the accepted range of 
precision (<10%).  
It should also be noted that over 98% of the fibers originally analyzed were 
analyzed again during the follow-up analysis for intra-class variance. Inter-class 
variance analysis could not be conducted on the muscle fiber CSA protocol because 
only one researcher conducted this protocol. Taken together, the low percent changes 
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yielded from these metrics indicate that the analysis protocols developed in this Honors 
Thesis are unbiased and appropriately rigorous in quantifying muscle CSA and volume.  
In addition to being meticulous, both procedures are more time efficient and 
allow for greater analysis capabilities in comparison to past techniques. The protocol for 
determining CSA of muscle cells is particularly expeditious and facilitates analysis of 
large quantities of cells in a reasonable time frame. Of the 14 subjects included in this 
study, 315 cells per biopsy on average were counted and analyzed for each subject 
using the described method. This is a notable increase from other studies measuring 
muscle fiber CSA, such as Dreyer et al.’s 2005 study comparing satellite cell numbers 
in young and older men after eccentric exercise, where, on average, only 119 fibers per 
biopsy per subject were analyzed47. The expanded analysis capacity of this method 
empowers this study even though it is impossible to conduct meaningful statistical 
analysis on the blinded data here.   
The protocol for determining quadriceps muscle volume is similarly efficient 
and dynamic. While exclusively employed to calculate quadriceps muscle volume in 
this study, it can easily be exploited to quantify hamstrings muscle volume (along with 
hamstrings intramuscular fat) and subcutaneous fat volume from the same MRI scans 
depicted in Figures 2 and 3.  The effectiveness of this protocol is further strengthened 
by the wide array of capabilities of MRI technology. The “fat” and “water” images 
provided by the Dixon technique facilitate accurate tissue differentiation and greatly 
simplify the process of quantifying otherwise hard to visualize or ambiguous muscle 
parameters (such as intramuscular fat).  
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The ability to cross-reference the same image under various filters imparts 
confidence during analysis and allows confirmation that manual selections (such as the 
tracing of intermuscular septums, Figure 3, Images 3 and 4) are as detailed as possible. 
The combination of versatile analysis techniques with comprehensive MR image data 
contributes to results that are detailed and reliably reproducible. 
Although the successes of essential amino acid supplementation in attenuating 
muscle atrophy after TKA cannot be directly assessed in this study, discussion of the 
potential advantageousness of this strategy in a clinical context is worthwhile. Findings 
from the Dreyer Lab provide proof-of principle for essential amino acid 
supplementation in mitigating muscle atrophy and the correlated functional declines 
after TKA9. Results concerning muscle fiber cross-sectional area from this study could 
further support these conclusions and ostensibly provide a mechanism for the observed 
retention of strength and functional mobility in patients supplementing EAAs. Although 
complex, the positive relationship between muscle fiber cross sectional area and 
strength in healthy young and older individuals has been established48,49,50,51.  
If EAA supplementation reduces muscle wasting at the cellular level, this could 
be a pertinent strategy in helping TKA patients retain strength, and ultimately maintain 
long-term functional mobility after surgery. The noninvasiveness of EAA 
supplementation makes it appealing in a clinical context, especially because it is not 
associated with adverse side effects or kidney damage.    
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Further research is necessary to determine how EAA supplementation affects the 
daily lives of patients, and if it is a universally realistic approach for all TKA patients. 
However, it remains that EAA supplementation has the capacity to be an exceedingly 
simple strategy in helping the rising number of individuals undergoing total knee 
arthroplasty to regain functional mobility and independence after surgery.  
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Appendix 
Listed below are subject-matched graphs for both quadriceps muscle cross-
sectional area (CSA) and volume. Data within these graphs remains blinded due to the 
stipulations described in the Results and Discussion.  
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